Patient 6 with breast cancer, characterized by diffuse FAP-positive bone and bone marrow metastases and lymph node metastases in 68Ga-FAP-2286 PET/CT imaging, displayed regression of bone and bone marrow lesions within 10 days (Figure 3b) [221]. This evidence concerns the gene FAP and breast cancer.